ASST vs CNS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 13, 2026

ASST

27.5
AI Score
VS
CNS Wins

CNS

51.9
AI Score

Investment Advisor Scores

ASST

28score
Recommendation
EXTENDED

CNS

52score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ASST CNS Winner
Forward P/E 5.0659 19.084 ASST
PEG Ratio 0 1.7476 Tie
Revenue Growth 94.6% 12.2% ASST
Earnings Growth 0.0% 31.9% CNS
Tradestie Score 27.5/100 51.9/100 CNS
Profit Margin 0.0% 28.8% CNS
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED HOLD Tie

Relative Price Performance (Last 90 Days)

ASST 1M: +122.9% · 3M: +89.4% CNS 1M: -11.6% · 3M: -1.4%

Current Technical Phase

ASST

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (23.4% over 20 days), RSI 82

RSI (14): 81.7 · Price: $27.62

CNS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 33

RSI (14): 32.6 · Price: $74.95

Fundamentals Snapshot

Metric ASST CNS
Market Cap
Forward P/E -25.5 18.8
Trailing P/E 23.7
Revenue (TTM)
Revenue Growth 0.9% 0.1%
Gross Margin -6.0% 0.5%
Operating Margin -84.8% 0.3%
EPS -1.12 3.23
Dividend Yield 0.03%

Frequently Asked Questions

Based on our detailed analysis, CNS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.